Please assess the completion status of the following clinical trial:

Trial Title: Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject with clinical diagnosis of moderate to severe facial acne vulgaris, defined by:~  1. Investigator's Global Assessment (IGA) score of 3 (Moderate) OR 4 (Severe ); and~ 2. A minimum of 25-100 inflammatory lesions (papules and pustules); and~ 3. A minimum of 30-150 non-inflammatory lesions (open and closed comedones) in total (excluding the nose); and~ 4. No more than two acne nodules (≥ 1 cm),~* Subject with skin phototype IV to VI on Fitzpatrick skin phototype scale,~* Subjects from one of the 3 ethnic/race backgrounds: Asian, Latin American and Black/African-American,~Exclusion Criteria:~* Subject with acne conglobata, acne fulminans, secondary acne (chloracne, drug-induced acne, etc.), nodulo cystic acne, acne requiring systemic treatment,~* Subject with history of lupus, atopic dermatitis, perioral dermatitis, dermatomyositis, rosacea~* Female subject who is pregnant, lactating or planning a pregnancy during the trial,~* Subjects having received at least one of the following topical treatments on the treated area: Corticosteroids, antibiotics, benzoyl peroxide, azelaic acid, dapsone, hydroxyacids, Zinc containing treatments, antiseptics, other anti-inflammatory products or other acne treatments (2 weeks); Retinoids (4 weeks); Cosmetic/aesthetic procedures on the face (1 week); Wax epilation (2 weeks); Photodynamic therapy (6 weeks); Laser therapy, microdermabrasion, deep chemical peel, plastic surgery for acne (3 months).~* Subjects having received at least one of the following systemic treatments: Corticosteroids, tetracyclines, other antibiotics (except penicillin) (1 month); Oral retinoids/isotretinoin/ anti-androgens / Cyproterone acetate / Chlormadinone acetate (6 months); Spironolactone/ Drospirenone (3 months); Immunomodulators (3 months) and Oral contraceptives/ oral dapsone for acne(1 month).

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Adapalene / BPO gel (Type: EXPERIMENTAL): Adapalene 0.3% / BPO 2.5% gel, once daily in the evening

Based on this trial design, predict the completion outcome and termination type (if applicable).